KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 77 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $671,000 | -30.1% | 50,000 | -50.0% | 1.32% | +58.6% |
Q4 2017 | $960,000 | -12.6% | 100,000 | 0.0% | 0.83% | -15.7% |
Q3 2017 | $1,098,000 | +21.3% | 100,000 | 0.0% | 0.98% | +18.8% |
Q2 2017 | $905,000 | +104.8% | 100,000 | +102.0% | 0.83% | +142.4% |
Q1 2016 | $442,000 | -44.4% | 49,500 | -17.5% | 0.34% | -34.9% |
Q4 2015 | $795,000 | +412.9% | 60,000 | +306.8% | 0.52% | +510.5% |
Q3 2015 | $155,000 | -66.2% | 14,750 | -1.7% | 0.09% | -77.7% |
Q1 2015 | $459,000 | – | 15,000 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |